CFO Sells $2.24M in Open Market Shares Following Resignation Announcement
SVRA has more than doubled off its 52-week low of $1.98.
Summary
Savara's CFO, David Lowrance, sold $2.24 million in open market shares and disposed of additional shares for tax purposes after exercising options, following his announced resignation.
Key Events · Ownership and Investor Activity · SVRA
-
CFO Sells Shares
David Lowrance, Savara's Chief Financial Officer, sold 394,528 shares in the open market for approximately $2.24 million.
-
Option Exercise and Tax Withholding
The open market sale followed the exercise of options valued at $1.02 million, with an additional $1.02 million in shares disposed for tax obligations.
-
Executive Departure Context
This transaction occurs after the company announced on June 8 that Mr. Lowrance would step down as CFO effective July 15 due to health-related reasons.
-
Significant Disposition
The total disposition of shares (open market sale plus tax withholding) amounts to over $3.26 million, representing 0.367% of the company's market capitalization.
Analysis · SVRA · Life Sciences
Savara's outgoing CFO, David Lowrance, sold over $2.24 million worth of common stock in the open market, in addition to shares disposed for tax withholding, following the exercise of options. This significant disposition of shares by a key executive, representing 0.367% of the company's market cap, occurs shortly after the announcement of his resignation effective July 15 due to health reasons. While the sale provides liquidity for the departing executive, it adds to the selling pressure on the stock.
At the time of this filing, SVRA was trading at $5.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $1.98 to $7.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.